Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: Pooled analysis within the ovarian cancer association consortium

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Lurie, Galina ^a   Wilkens, Lynne R ^a   Thompson, Pamela J ^a   Shvetsov, Yurii B ^a   Matsuno, Rayna K ^a,b   Carney, Michael E ^c   Palmieri, Rachel T ^d   Wu, Anna H ^e   Pike, Malcolm C ^e,f   Pearce, Celeste L ^e   Menon, Usha ^g   Gentry Maharaj, Aleksandra ^g   Gayther, Simon A ^e   Ramus, Susan J ^e   Whittemore, Alice S ^h   McGuire, Valerie ^h   Sieh, Weiva ^h   Pharoah, Paul D P ⁱ   Song, Honglin ⁱ   Gronwald, Jacek ^j   Jakubowska, Anna ^j   Cybulski, Cezary ^j   Lubinski, Jan ^j   Schildkraut, Joellen M ^d   Berchuck, Andrew ^d   Kjær, Susanne ^k,l   Høgdall, Estrid ^k   Fasching, Peter A ^m   Beckmann, Matthias W ⁿ   Ekici, Arif B ^o   Hein, Alexander ⁿ   Chenevix Trench, Georgia ^p   Webb, Penelope M ^p   Beesley, Jonathan ^p   The Australian Ovarian Cancer Study and Australian Cancer Study Groups, ^p,q   Goodman, Marc T ^a   The Ovarian Cancer Association Consortium, ^r   more..

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j POMERANIAN MEDICAL UNIVERSITY   (Poland)

^k INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^l UNIVERSITY OF COPENHAGEN   (Denmark)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^o UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^p QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^q PETER MACCALLUM CANCER CENTRE   (Australia)

^r NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN RECEPTOR BETA; HORMONE;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CANCER STAGING; CAUCASIAN; CONTRACEPTION; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MOLECULAR PATHOLOGY; OVARY CARCINOMA; PARITY; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; CANCER INVASION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEALTH CARE ORGANIZATION; MIDDLE AGED; OVARY TUMOR; PATHOLOGY;

ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; SOCIETIES, SCIENTIFIC;

EID: 79958128164     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020703     Document Type: Article

References (26)

1. Henderson BE, Ross R, Bernstein L, (1988) Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 48: 246-253.
2. Zhao C, Dahlman-Wright K, Gustafsson JA, (2010) Estrogen signaling via estrogen receptor {beta}. J Biol Chem 285: 39575-39579 R110.180109 [pii];10.1074/jbc.R110.180109 [doi].
3. Enmark E, Gustafsson JA, (1999) Oestrogen receptors- an overview. J Intern Med 246: 133-138.
4. Byers M, Kuiper GG, Gustafsson JA, Park-Sarge OK, (1997) Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins. Mol Endocrinol 11: 172-182.
5. Drummond AE, Baillie AJ, Findlay JK, (1999) Ovarian estrogen receptor alpha and beta mRNA expression: impact of development and estrogen. Mol Cell Endocrinol 149: 153-161 S0303-7207(98)00247-0 [pii].
6. Drummond AE, Fuller PJ, (2010) The importance of ERbeta signalling in the ovary. J Endocrinol 205: 15-23 JOE-09-0379 [pii];10.1677/JOE-09-0379 [doi].
7. Li AJ, Baldwin RL, Karlan BY, (2003) Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures. Am J Obstet Gynecol 189: 22-27.
8. Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P, (2004) Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 11: 537-551.
9. Lindgren PR, Cajander S, Backstrom T, Gustafsson JA, Makela S, et al. (2004) Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol 221: 97-104 10.1016/j.mce.2004.02.020 [doi];S0303720704000462 [pii].
10. Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, et al. (2004) Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Res 64: 5861-5869.
11. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, et al. (2009) Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma. Cancer Causes Control 20: 47-55 10.1007/s10552-008-9216-8 [doi].
12. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, et al. (2009) Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer 100: 412-420 6604820 [pii];10.1038/sj.bjc.6604820 [doi].
13. Berchuck A, Schildkraut JM, Pearce CL, Chenevix-Trench G, Pharoah PD, (2008) Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium. Adv Exp Med Biol 622: 53-67 10.1007/978-0-387-68969-2_5 [doi].
14. Li LC, Yeh CC, Nojima D, Dahiya R, (2000) Cloning and characterization of human estrogen receptor beta promoter. Biochem Biophys Res Commun 275: 682-689.
15. Hu YF, Luscher B, Admon A, Mermod N, Tjian R, (1990) Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev 4: 1741-1752.
16. Alarid ET, Bakopoulos N, Solodin N, (1999) Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13: 1522-1534.
17. Cheng J, Lee EJ, Madison LD, Lazennec G, (2004) Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 566: 169-172.
18. Treeck O, Pfeiler G, Mitter D, Lattrich C, Piendl G, et al. (2007) Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells. J Endocrinol 193: 421-433.
19. Park BW, Kim KS, Heo MK, Ko SS, Hong SW, et al. (2003) Expression of estrogen receptor-beta in normal mammary and tumor tissues: is it protective in breast carcinogenesis? Breast Cancer Res Treat 80: 79-85.
20. Fixemer T, Remberger K, Bonkhoff H, (2003) Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 54: 79-87.
21. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW, (2000) Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 60: 245-248.
22. Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, et al. (2004) Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives. Am J Epidemiol 159: 750-758.
23. Pearce CL, Near AM, Butler JL, Van Den Berg D, Bretsky P, et al. (2008) Comprehensive evaluation of ESR2 Variation and ovarian cancer risk. Cancer Epidemiology, Biomarkers, & Prevention 17: 393-396.
24. Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, et al. (2009) A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 41: 996-1000 ng.424 [pii];10.1038/ng.424 [doi].
25. Sun YH, Yang B, Wang XH, Xu CL, Gao XF, et al. (2005) [Association between single-nucleotide polymorphisms in estrogen receptor beta gene and risk of prostate cancer]. Zhonghua Wai Ke Za Zhi 43: 948-951.
26. Wacholder S, Chanock S, Garcia-Closas M, El GL, Rothman N, (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96: 434-442.